The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania

Free Radical Biology and Medicine

Volumn 46, Issue 3, 2009, Pages 367-375

  Moreira, Wilfried ^a   Leblanc, Éric ^a   Ouellette, Marc ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Free radicals; Macrophages; Nitric oxide; Pteridine reductase; Pterins; Reactive oxygen species

Indexed keywords

NITRIC OXIDE; PTERIN DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ARTICLE; EXPERIMENTAL MOUSE; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TARENTOLAE; MACROPHAGE; MOUSE; MUTANT; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL;

LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TARENTOLAE; PROTOZOA;

EID: 58149101954     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.10.034     Document Type: Article

References (68)

1. Olivier M., Gregory D.J., and Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18 (2005) 293-305
2. Bogdan C., and Rollinghoff M. How do protozoan parasites survive inside macrophages?. Parasitol. Today 15 (1999) 22-28
3. Nathan C., and Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97 (2000) 8841-8848
4. Sacks D., and Sher A. Evasion of innate immunity by parasitic protozoa. Nat. Immunol. 3 (2002) 1041-1047
5. Murray H.W. Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J. Exp. Med. 153 (1981) 1302-1315
6. Liew F.Y., Millott S., Parkinson C., Palmer R.M., and Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144 (1990) 4794-4797
7. Murray H.W., and Nathan C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189 (1999) 741-746
8. Gantt K.R., Goldman T.L., McCormick M.L., Miller M.A., Jeronimo S.M., Nascimento E.T., Britigan B.E., and Wilson M.E. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167 (2001) 893-901
9. Mukbel R.M., Patten Jr. C., Gibson K., Ghosh M., Petersen C., and Jones D.E. Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am. J. Trop. Med. Hyg. 76 (2007) 669-675
10. Olivier M., Brownsey R.W., and Reiner N.E. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc. Natl. Acad. Sci. USA 89 (1992) 7481-7485
11. Moore K.J., Labrecque S., and Matlashewski G. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. J. Immunol. 150 (1993) 4457-4465
12. Fairlamb A.H., Blackburn P., Ulrich P., Chait B.T., and Cerami A. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 227 (1985) 1485-1487
13. Spies H.S., and Steenkamp D.J. Thiols of intracellular pathogens: identification of ovothiol A in Leishmania donovani and structural analysis of a novel thiol from Mycobacterium bovis. Eur. J. Biochem. 224 (1994) 203-213
14. Ariyanayagam M.R., and Fairlamb A.H. Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol. Biochem. Parasitol. 115 (2001) 189-198
15. Krauth-Siegel L.R., Comini M.A., and Schlecker T. The trypanothione system. Subcell. Biochem. 44 (2007) 231-251
16. Irigoin F., Cibils L., Comini M.A., Wilkinson S.R., Flohé L., and Radi R. Insights into the redox biology of Trypanosoma cruzi: trypanothione metabolism and oxidant detoxification. Free Radic. Biol. Med. 45 (2008) 733-742
17. Barr S.D., and Gedamu L. Role of peroxidoxins in Leishmania chagasi survival: evidence of an enzymatic defense against nitrosative stress. J. Biol. Chem. 278 (2003) 10816-10823
18. Plewes K.A., Barr S.D., and Gedamu L. Iron superoxide dismutases targeted to the glycosomes of Leishmania chagasi are important for survival. Infect. Immun. 71 (2003) 5910-5920
19. Wilkinson S.R., Prathalingam S.R., Taylor M.C., Ahmed A., Horn D., and Kelly J.M. Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei. Free Radic. Biol. Med. 40 (2006) 198-209
20. Chan J., Fujiwara T., Brennan P., McNeil M., Turco S.J., Sibille J.C., Snapper M., Aisen P., and Bloom B.R. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc. Natl. Acad. Sci. USA 86 (1989) 2453-2457
21. Spath G.F., Garraway L.A., Turco S.J., and Beverley S.M. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. USA 100 (2003) 9536-9541
22. Lodge R., Diallo T.O., and Descoteaux A. Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane. Cell. Microbiol. 8 (2006) 1922-1931
23. Miller M.A., McGowan S.E., Gantt K.R., Champion M., Novick S.L., Andersen K.A., Bacchi C.J., Yarlett N., Britigan B.E., and Wilson M.E. Inducible resistance to oxidant stress in the protozoan Leishmania chagasi. J. Biol. Chem. 275 (2000) 33883-33889
24. Kündig C., Haimeur A., Légaré D., Papadopoulou B., and Ouellette M. Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae. EMBO J. 18 (1999) 2342-2351
25. Lemley C., Yan S., Dole V.S., Madhubala R., Cunningham M.L., Beverley S.M., Myler P.J., and Stuart K.D. The Leishmania donovani LD1 locus gene ORFG encodes a biopterin transporter (BT1). Mol. Biochem. Parasitol. 104 (1999) 93-105
26. Nare B., Hardy L.W., and Beverley S.M. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major. J. Biol. Chem. 272 (1997) 13883-13891
27. Wang J., Leblanc E., Chang C.F., Papadopoulou B., Bray T., Whiteley J.M., Lin S.X., and Ouellette M. Pterin and folate reduction by the Leishmania tarentolae H locus short-chain dehydrogenase/reductase PTR1. Arch. Biochem. Biophys. 342 (1997) 197-202
28. Lye L.F., Cunningham M.L., and Beverley S.M. Characterization of quinonoid-dihydropteridine reductase (QDPR) from the lower eukaryote Leishmania major. J. Biol. Chem. 277 (2002) 38245-38253
29. Thony B., Auerbach G., and Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J. 347 Pt 1 (2000) 1-16
30. Trager W. Pteridine requirement of the hemoflagellate Leishmania tarentolae. J. Protozool. 16 (1969) 372-375
31. Bello A.R., Nare B., Freedman D., Hardy L., and Beverley S.M. PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. USA 91 (1994) 11442-11446
32. Papadopoulou B., Roy G., Mourad W., Leblanc E., and Ouellette M. Changes in folate and pterin metabolism after disruption of the Leishmania H locus short chain dehydrogenase gene. J. Biol. Chem. 269 (1994) 7310-7315
33. Roy G., Kundig C., Olivier M., Papadopoulou B., and Ouellette M. Adaptation of Leishmania cells to in vitro culture results in a more efficient reduction and transport of biopterin. Exp. Parasitol. 97 (2001) 161-168
34. Werner-Felmayer G., Golderer G., and Werner E.R. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr. Drug Metab. 3 (2002) 159-173
35. Nare B., Luba J., Hardy L.W., and Beverley S. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Parasitology 114 Suppl. (1997) S101-110
36. Ouellette M., Drummelsmith J., El Fadili A., Kundig C., Richard D., and Roy G. Pterin transport and metabolism in Leishmania and related trypanosomatid parasites. Int. J. Parasitol. 32 (2002) 385-398
37. Cunningham M.L., Titus R.G., Turco S.J., and Beverley S.M. Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science 292 (2001) 285-287
38. Oettl K., and Reibnegger G. Pteridine derivatives as modulators of oxidative stress. Curr. Drug Metab. 3 (2002) 203-209
39. Wei C.C., Crane B.R., and Stuehr D.J. Tetrahydrobiopterin radical enzymology. Chem. Rev. 103 (2003) 2365-2383
40. Mayahi L., Heales S., Owen D., Casas J.P., Harris J., MacAllister R.J., and Hingorani A.D. (6R)-5,6,7,8-tetrahydro-l-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1334-1339
41. Ouellette M., Fase-Fowler F., and Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9 (1990) 1027-1033
42. Feelisch M., Ostrowski J., and Noack E. On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14 Suppl. 11 (1989) S13-22
43. Darveau A., Pelletier A., and Perreault J. PCR-mediated synthesis of chimeric molecules. Methods Neurosci. 26 (1995) 77-85
44. Papadopoulou B., Roy G., and Ouellette M. A novel antifolate resistance gene on the amplified H circle of Leishmania. EMBO J. 11 (1992) 3601-3608
45. Sacks D.L., Hieny S., and Sher A. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135 (1985) 564-569
46. Stuehr D.J., and Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82 (1985) 7738-7742
47. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., and Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268 (1993) 1908-1913
48. Kim J.S., Kwon H.Y., Choi W.H., Jeon C.Y., Kim J.I., Kim J., Lee J.Y., Kim Y.S., and Park J.B. Phagocytosis of serum- and IgG-opsonized zymosan particles induces apoptosis through superoxide but not nitric oxide in macrophage J774A.1. Exp. Mol. Med. 35 (2003) 211-221
49. Wan C.P., Myung E., and Lau B.H. An automated micro-fluorometric assay for monitoring oxidative burst activity of phagocytes. J. Immunol. Methods 159 (1993) 131-138
50. Griess J. On a new series of bodies in which nitrogen is substituted for hydrogen. Philos. Trans. R. Soc. London 154 (1864) 667-731
51. Roy G., Dumas C., Sereno D., Wu Y., Singh A.K., Tremblay M.J., Ouellette M., Olivier M., and Papadopoulou B. Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol. Biochem. Parasitol. 110 (2000) 195-206
52. Sereno D., Roy G., Lemesre J.L., Papadopoulou B., and Ouellette M. DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob. Agents Chemother. 45 (2001) 1168-1173
53. El Fadili K., Imbeault M., Messier N., Roy G., Gourbal B., Bergeron M., Tremblay M.J., Legare D., and Ouellette M. Modulation of gene expression in human macrophages treated with the anti-Leishmania pentavalent antimonial drug sodium stibogluconate. Antimicrob. Agents Chemother. 52 (2008) 526-533
54. Kojima H., Urano Y., Kikuchi K., Higuchi T., Hirata Y., and Nagano T. Fluorescent indicators for imaging nitric oxide production. Angew. Chem. Int. Ed. Engl. 38 (1999) 3209-3212
55. El Fadili A., Kundig C., Roy G., and Ouellette M. Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate. J. Biol. Chem. 279 (2004) 18575-18582
56. Callahan H.L., and Beverley S.M. A member of the aldoketo reductase family confers methotrexate resistance in Leishmania. J. Biol. Chem. 267 (1992) 24165-24168
57. Sen N., Das B.B., Ganguly A., Mukherjee T., Tripathi G., Bandyopadhyay S., Rakshit S., Sen T., and Majumder H.K. Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani. Cell Death Differ. 11 (2004) 924-936
58. Mandal G., Wyllie S., Singh N., Sundar S., Fairlamb A.H., and Chatterjee M. Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology 134 (2007) 1679-1687
59. Fang F.C. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2 (2004) 820-832
60. Basu N.K., Kole L., Ghosh A., and Das P.K. Isolation of a nitric oxide synthase from the protozoan parasite, Leishmania donovani. FEMS Microbiol. Lett. 156 (1997) 43-47
61. Lodge R., and Descoteaux A. Phagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activation. Eur. J. Immunol. 36 (2006) 2735-2744
62. Hardy L.W., Matthews W., Nare B., and Beverley S.M. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways. Exp. Parasitol. 87 (1997) 157-169
63. Cavazzuti A., Paglietti G., Hunter W.N., Gamarro F., Piras S., Loriga M., Allecca S., Corona P., McLuskey K., Tulloch L., Gibellini F., Ferrari S., and Costi M.P. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development. Proc. Natl. Acad. Sci. USA 105 (2008) 1448-1453
64. Ouellette M., and Papadopoulou B. Mechanisms of drug resistance in Leishmania. Parasitol. Today 9 (1993) 150-153
65. Kojima S., Ona S., Iizuka I., Arai T., Mori H., and Kubota K. Antioxidative activity of 5,6,7,8-tetrahydrobiopterin and its inhibitory effect on paraquat-induced cell toxicity in cultured rat hepatocytes. Free Radic. Res. 23 (1995) 419-430
66. Oettl K., Greilberger J., Dikalov S., and Reibnegger G. Interference of 7,8-dihydroneopterin with peroxynitrite-mediated reactions. Biochem. Biophys. Res. Commun. 321 (2004) 379-385
67. Beverley S.M. Gene amplification in Leishmania. Annu. Rev. Microbiol. 45 (1991) 417-444
68. Borst P., and Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49 (1995) 427-460